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Abstract
The chronic phase of HIV infection is marked by pathological activation of the immune system, the extent of which better
predicts disease progression than either plasma viral load or CD4
+ T cell count. Recently, translocation of microbial products
from the gastrointestinal tract has been proposed as an underlying cause of this immune activation, based on indirect
evidence including the detection of microbial products and specific immune responses in the plasma of chronically HIV-
infected humans or SIV-infected Asian macaques. We analyzed tissues from SIV-infected rhesus macaques (RMs) to provide
direct in situ evidence for translocation of microbial constituents from the lumen of the intestine into the lamina propria and
to draining and peripheral lymph nodes and liver, accompanied by local immune responses in affected tissues. In chronically
SIV-infected RMs this translocation is associated with breakdown of the integrity of the epithelial barrier of the
gastrointestinal (GI) tract and apparent inability of lamina propria macrophages to effectively phagocytose translocated
microbial constituents. By contrast, in the chronic phase of SIV infection in sooty mangabeys, we found no evidence of
epithelial barrier breakdown, no increased microbial translocation and no pathological immune activation. Because immune
activation is characteristic of the chronic phase of progressive HIV/SIV infections, these findings suggest that increased
microbial translocation from the GI tract, in excess of capacity to clear the translocated microbial constituents, helps drive
pathological immune activation. Novel therapeutic approaches to inhibit microbial translocation and/or attenuate chronic
immune activation in HIV-infected individuals may complement treatments aimed at direct suppression of viral replication.
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Introduction
Persistently elevated immune activation characterized by
polyclonal B cell activation [1], increased T-cell turnover [2],
increased frequencies of T cells with an activated phenotype [3],
and increased levels of pro-inflammatory molecules [4] is a
hallmark of disease progression in pathogenic HIV/SIV primate
lentiviral infections and is a stronger predictor of disease
progression than either CD4
+ T-cell count or plasma viral load
[5]. The importance of immune activation to disease progression
in HIV/SIV infections is highlighted by the low levels of immune
activation measured during the chronic phase of infection in
natural hosts of SIV such as African green monkeys (AGMs) and
Sooty mangabeys (SMs), which do not progress to AIDS [6].
While the consequences of immune activation in HIV/SIV
infection are numerous and include increased numbers of
activated CD4
+ T-cell targets for the virus, attrition of the
memory CD4
+ T-cell pool and accumulation of high frequencies
of terminally differentiated and exhausted memory T and B cells,
the underlying mechanisms and sources of immune activation
during infection are not well understood [7,8]. Given accumulat-
ing evidence that persistent immune activation is at the heart of
disease progression, understanding the mechanisms driving
immune activation in chronic HIV disease will be important for
the development of new adjunctive treatment strategies targeting
this process. Although many factors may contribute to immune
activation during chronic HIV/SIV infection, recent evidence has
indicated that translocation of microbial products from the lumen
PLoS Pathogens | www.plospathogens.org 1 August 2010 | Volume 6 | Issue 8 | e1001052of the intestine into the periphery may contribute importantly to
this process [9,10,11,12,13,14]. These microbial products can
stimulate immune cells directly via pattern recognition receptors
such as toll-like receptors. Indeed, immune activation related to
microbial translocation occurs in other settings and has been
implicated in many other pathological conditions. For example,
the preconditioning chemotherapy and radiation prior to
progenitor stem cell transplantation in individuals with hemato-
logical malignancies leads to damage of the tight epithelial barrier
of the gastrointestinal (GI) tract resulting in microbial translocation
[15]. These translocated microbial products can then stimulate the
immune system, exacerbating graft versus host disease [16,17,18].
Microbial translocation leading to immune activation also occurs
in inflammatory bowl disease [19], after invasive surgery [20,21],
and in pancreatitis [22].
While microbial translocation has been indirectly implicated in
driving immune activation in chronically HIV-infected humans
and SIV-infected rhesus macaques (RMs), the mechanisms
underlying this phenomenon remain unclear, with enterocyte
apoptosis [23], massive loss of GI tract CD4
+ T cells [24] and/or
preferential loss of GI tract Th17 cells [25,26] all proposed as
important contributing factors. Moreover, the timing of the onset
of microbial translocation relative to infection has remained
obscure, and direct evidence of translocation at the tissue level
has been lacking. Here, using a quantitative image analysis
approach to study large segments of tissue, we provide direct
immunohistochemical evidence of translocation, define the
timing of microbial translocation in pathogenic SIV infection of
RMs and identify loss of the integrity of the intestinal epithelial
barrier as a plausible mechanistic correlate of microbial
translocation. The absence of translocation or associated immune
activation in chronic SIV infection of SMs, which does not result
in progressive disease, underscores the critical role this process
plays in the pathogenesis of primate lentiviral infections and the
potential value of limiting it as an approach to adjunctive
therapy.
Results
In vivo detection of microbial translocation and host
responses in tissues of SIV infected RMs
Initially, we sought evidence of microbial translocation by
staining with a monoclonal antibody against LPS-core antigen in
paraffin-embedded colon tissue sections obtained at necropsy from
SIV-uninfected RMs (n=6), RMs euthanized during early acute
(n=10) or late acute (n=3) SIV infection, and chronically SIV-
infected RMs euthanized at protocol specified endpoints (‘‘Non-
AIDS’’; n=8) or clinical endpoints (AIDS defining conditions,
‘‘AIDS’’; n=5, Table 1). Prior to and during early acute SIV
infection, the LPS-core antigen-specific mAb stained only rare
cells within the lamina propria (LP), but in dramatic contrast, in
chronically infected animals both numerous LPS
+ cells and
abundant extracellular core LPS antigen were observed
(Figures 1 and S1). Figures show a broad spectrum of microbial
tanslocation and discontinuities to the structural barrier of the GI
tract (discussed in detail below) that was seen in our animal cohort,
from negligible (SIV-) to most severe (AIDS). Although the
amount of apparently extracellular bacterial constituents within
the LP varied among our chronically SIV-infected RMs; all
chronically SIV-infected RMs showed readily demonstrable
evidence of microbial translocation in multifocial lesions along
the GI tract, findings that were absent in the SIV-uninfected
animals and in early acute SIV infection (i.e. 1–10 dpi).
Importantly, microbial translocation was evident in the large
bowel of RMs chronically-infected with different pathogenic
strains of virus (i.e. SIVmac239, SIVmac251 and SIVsmE660;
Table 1), suggesting that intestinal damage leading to microbial
translocation is a common feature of pathogenic SIV infections.
The specificity of our immunohistochemical staining directly
documenting microbial translocation in gut tissue sections is
supported by: (i) the remarkably low frequency of LPS
+ cells within
the LP in SIV-uninfected or RMs with early acute infection; (ii) the
absence of staining with isotype-matched control antibodies in
SIV-uninfected, acutely and chronically SIV-infected animals
(data not shown); (iii) the lack of any evidence of non-cell
associated LPS in the LP of our SIV-uninfected and early acute
SIV-infected RMs, despite the abundant LPS staining in the
residual luminal content of these same samples; (iv) the detection of
microbial products within the LP of the colon of chronically SIV-
infected RMs that were rarely seen in SIV-uninfected and early
acute infected RMs, using a rabbit polyclonal antibody against
Escherichia coli that recognizes many E. coli proteins (Figures 2 and
S2), or using peptide nucleic acid fluorescent in situ hybridization
to detect bacterial 16S RNA (data not shown).
To relate microbial translocationinthe large bowel of chronically
SIV-infected RMs to systemic microbial translocation, we stained
sections from lymph nodes, identifying large numbers of LPS
+ cells
within both local draining lymph nodes (mesenteric; MesLN)
(Figures 3 and S3), and remote peripheral lymph nodes (axillary;
AxLN) (Figures 4 and S4) of chronically SIV-infected RMs,
suggesting systemic dissemination of translocated microbial constit-
uents originating from the GI tract. Consistent with what might be
expected for the anatomic site of inductive T-cell immune
responses, we found immunoreactive LPS within the medullary
cords and paracortex of draining MesLN as well as peripheral
AxLN during the chronic stage of infection. In contrast, in SIV-
uninfected or early/acute SIV-infected RMs we found only low
levels of LPS
+ cells in the gut-draining MesLN and virtually no
LPS+ cells in the peripheral AxLN of (Figures 3,4 S3 and S4). The
primary localization of LPS within the medullary cords and sinuses,
and to a lesser extent the paracortex and germinal centers, in SIV
+
Author Summary
Persistent activation of the immune system is a hallmark of
chronic HIV/SIV infections and predicts disease progression
better than either plasma viral load or CD4
+ T cell count.
While the causes of immune activation during chronic
infection are likely multifactorial, recent work has shown
that microbial translocation is associated with immune
activation. However, direct, tissue level in vivo evidence of
translocation and the underlying mechanisms remain
unclear. Here, we sought direct in vivo evidence of
translocation, and an understanding of the timing and
the underlying mechanisms. We found that in RMs,
microbial translocation begins during the late acute phase
of SIV infection and increases progressively during chronic
infection and is associated with structural damage of the
GI tract. We further discovered that immune activation is
temporally and causally related to microbial translocation
and by the relative inability of intestinal macrophages to
bind/phagocytose translocated microbial products. In SIV-
infected sooty mangabeys, however, no evidence of
epithelial barrier breakdown, nor increased microbial
translocation or chronic immune activation were observed.
Our results provide direct evidence for microbial translo-
cation in vivo, coupled with early and progressive intestinal
epithelial damage, and eventual impairment of macro-
phage clearance associated with dissemination of micro-
bial products and systemic immune activation.
Mechanisms Underlying Microbial Translocation
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Animal ID Species Virus
Days post
infection
Infection
Status Major Pathologic/Clinical Findings
Opportunistic
Infections pVL
a
595 RM None Uninfected - ND None NA
DBM6 RM None Uninfected - ND None NA
34572A RM None Uninfected - Pneumoconiosis None NA
04D169 RM None Uninfected - ND None NA
P049 RM None Uninfected - ND None NA
27776
b RM AT-2 SIVmac251 Uninfected - ND None NA
23053 RM SIVmac251 1 Early Acute Endometriosis, moderate None ,125
30127 RM SIVmac251 1 Early Acute Splenomegaly, mild None ,125
31373 RM SIVmac251 4 Early Acute Parathyroid Nodule None ,125
31385 RM SIVmac251 4 Early Acute Gastritis None 1.5610
3
30991 RM SIVmac251 6 Early Acute Cervical Ectopy None 2.3610
4
31523 RM SIVmac251 6 Early Acute Generalized Lymphadenopathy,
moderate
None 7.3610
4
26222 RM SIVmac251 7 Early Acute Lymphadenopathy, mild;
Splenomegaly, mild; Intussusception,
Ileocecal
None 2.6610
6
34498 RM SIVmac251 8 Early Acute Lymphadenopathy, generalized,
marked
None 2.5610
6
28013 RM SIVmac251 9 Early Acute Lymphadenopathy, mild;
Cervical ectopy
None 2.5610
6
24818 RM SIVmac251 10 Early Acute Lymphadenopathy, generalized,
moderate-marked
None 9.9610
6
24037 RM SIVmac239 14 Late Acute Lymphadenopathy, generalized,
marked; Splenomegaly; Hepatic
Lipidosis; Endometritis, mild, Chronic
None 2.3610
8
27099 RM SIVmac239 21 Late Acute Lymphadenopathy, generalized None 6.8610
6
24225 RM SIVmac239 28 Late Acute No significant findings None 1.5610
6
551 RM SIVmac239 168 Chronic/Non-AIDS Lymphadenopathy, generalized,
moderate; Lymphocytic portal
inflammation, moderate multifocal;
Pulmonary lymphoid hyperplasia,
marked
None 1.0610
6
83I RM SIVmac239 168 Chronic/Non-AIDS Renal lymphofollicular inflammation,
mild focal
None 1.4610
6
AD09 RM SIVmac239 161 Chronic/Non-AIDS Lymphadenopathy, generalized,
moderate; Portal hapatitis, chronic
suppurative with fibrosis
None 2.7610
6
AY25 RM SIVmac239 273 Chronic/Non-AIDS Lymphadenopathy, mild; Gastritis,
minimal; Colitis, mild with mucosal
hyperplasia
None 3.5610
5
(30)
c
AY44 RM SIVmac239 273 Chronic/Non-AIDS Lymphadenopathy, follicular, mild;
Colitis, mild with mucosal hyperplasia;
Hepatitis, mild; Nephritis, mild
None 2.010
6 (55)
c
R443
d RM SIVmac239 391 Chronic/Non-AIDS No apparent clinical manifestations
of disease
ND 1.4610
5
R457
d RM SIVmac239 397 Chronic/Non-AIDS Chronic diarrhea and recurrent
epistaxis
ND 8.4610
5
R462
d RM SIVmac239 396 Chronic/Non-AIDS Weight loss ND 2.8610
5
AY99 RM SIVmac239 213 Chronic/AIDS Lymphadenopathy, generalized,
moderate; Gastritis, mild-moderate;
Colitis; mild with multifocal lymphoid
follicles; Enteritis, multifocal and
focally extensive with no overt OIs.
CMV meningitis,
buccal Candida
1.0610
7
R451
e RM SIVmac239 148 Chronic/AIDS Chronic diarrhea, weight loss and
cutaneous lesions; Enteritis,
multifocal and focally extensive
with no overt OIs.
NF 4.1610
7f
Mechanisms Underlying Microbial Translocation
PLoS Pathogens | www.plospathogens.org 3 August 2010 | Volume 6 | Issue 8 | e1001052Non-AIDS RMs is consistent with microbial products traversing
from thedamaged intestinevia thelymphatics. The presence ofLPS
within the paracortex and germinal centers suggests a) antigen
presenting cells which have bound microbial antigens migrate into
the T cell inductive site ofthe LN and b) possibly microbial product-
immune complex deposition on follicular dendritic cells may be
occurring. However, the biological relevance of finding microbial
constituents in these anatomical sites, at this point, remains unclear.
Moreover, consistent with the liver’s important function as a
‘‘gatekeeper’’ between the intestine and peripheral circulation, we
also found multifocal evidence of microbial products within the
liver, in regions surrounding the hepatic portal veins and tracts in
chronically SIV-infected Non-AIDS RMs with more extensive
staining into the lobules of the liver in chronically SIV-infected
AIDS RMs, consistent with increased intestinal damage correlating
with more microbial dissemination (Figure 5 and Figure S5).
Using these approaches, we identified unequivocal direct
evidence of microbial constituents within the LP of the large
bowel, and in the liver and lymph nodes of all chronically SIV-
infected RMs studied, but not uninfected RMs. This finding was
Animal ID Species Virus
Days post
infection
Infection
Status Major Pathologic/Clinical Findings
Opportunistic
Infections pVL
a
R475
e RM SIVmac239 195 Chronic/AIDS Chronic diarrhea, intermittent epistaxis
and weight loss; Enteritis, multifocal and
focally extensive with no overt OIs.
NF 7.6610
8
R268
e RM SIVsmE660 56 Chronic/AIDS Chronic diarrhea, Polyuria/Polydipsia
and weight loss; Enteritis, multifocal
and focally extensive with no overt OIs.
NF 1.4610
9
R437
e RM SIVsmE660 184 Chronic/AIDS Chronic diarrhea and weight loss;
Enteritis, extensive with no overt OIs.
NF 7.8610
6
FOu SM None Uninfected - NR None NA
FZr SM None Uninfected - NR None NA
FAv SM SIVsmm Naturally
infected
Non-AIDS NR None 1.0610
4g
FBn SM SIVsmm Naturally
infected
Non-AIDS NR None 3.1610
4g
FBq SM SIVsmm Naturally
infected
Non-AIDS NR None 4.1610
4g
FFq SM SIVsmm Naturally
infected
Non-AIDS NR None 3.5610
4g
FKn SM SIVsmm Naturally
infected
Non-AIDS NR None 1.2610
4g
aViral loads are SIV vRNA copies/mL of plasma and the detection limit of this assay was 125 copies of vRNA/ml ofplasma as reported previously [53].
bAnimal 27776 was given
i.vag. aldithriol-2 (AT-2)-inactivated SIVmac239, using the same inoculation schedule as that for the other animals inoculated i.vag. with SIVmac. This animal, had no signs of
infection and was considered an uninfected control.
cViral loads measured 1 week prior being placed on an ART regimen, which lasted 5 weeks. Parentheses are viral load
measurements at time of euthanasia (i.e. 5 weeks post ART).
dPathology reports were not available for these animals, thus only major clinical findings are reported but
ehaematoxylin and eosin stains were examined on tissues when possible. However, we did have sufficient tissue to perform large bowel histopathological evaluation, which
are also reported.
fViral load measured 4 weeks before euthanasia.
gViral load at time of tissue biopsy. ND, not determined. NR, not relevant, NF, none found.
doi:10.1371/journal.ppat.1001052.t001
Table 1. Cont.
Figure 1. Identification of microbial translocation in large bowel of chronically SIV
+ RMs. Representative images (2006) of unselected
colon sections from SIV-uninfected and chronically SIV-infected RMs (Non-AIDS and AIDS) stained for LPS-core antigen (brown). The images show the
array of microbial translocation and damage seen in our cohort that ranged from negligible (SIV- RMs) to regions of epithelial loss in our SIV
+ Non-
AIDS RMs resulting in luminal content in direct contact with the LP and increased frequency of LPS
+ cells within the LP to more extensive epithelial
damage in our SIV
+ AIDS RMs that extended to overt ulcerations that showed significant microbial product infiltration throughout these regions;
features which were absent from our SIV-uninfected RMs. Arrows point to regions of epithelial discontinuities and microbial translocation into the LP.
doi:10.1371/journal.ppat.1001052.g001
Mechanisms Underlying Microbial Translocation
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RMs (n=6); early acute SIV-infected RMs (1–10 dpi, n=10); late
acute RMs (14–28 dpi infection, n=3); and chronically SIV-
infected RMs (56–397 dpi, n=13 (Non-AIDS and AIDS); Table 1)
and indicate that microbial translocation involves infiltration of
microbial products into the LP of the GI tract during the chronic
phase of SIV infection of RMs.
Quantitative image analysis of microbial translocation
After demonstrating the qualitative presence of increased
microbial products in the LP of large bowel, liver and lymph
nodes of SIV infected RMs, we used quantitative image analysis
techniques [27] to quantify the extent of microbial translocation
demonstrable in high power (4006) digital scans, of tissue section
whole mounts (ScanScope CS System, Aperio). Sections of colonic
mucosa analyzed for each animal represented, on average, a total
of 350 distinct 4006image fields per scanned tissue, providing an
in-depth, systematic, assessment of segments of the GI tract that
ranged from 43 to 101 linear mm of colonic epithelial lining and
16 to 39 mm
2 of intestinal mucosal area. This comprehensive
analysis approach, applied to randomly selected tissue sections,
provided us with an unbiased and detailed evaluation of microbial
translocation in representative sections of the GI tract that
otherwise may not have been possible using conventional
established tissue analysis methods. Using this approach, we found
that the percent area of LP of the colonic mucosa containing LPS
was significantly higher in chronically-infected RMs compared to
uninfected and acutely (early) SIV-infected RMs (Figure 6A).
We used the same quantitative image analysis approach to
evaluate the relationship between the microbial product burden
within the LP of the colon and in draining (MesLN) and distant
LN (AxLN) from the same animals, calculating the percent area
of each tissue that contained LPS. We found a significant
positive correlation between the amount of LPS within the LP of
the colon and the amount of LPS within the corresponding
draining MesLN (r=0.69, P=0.0065, Figure 6B). Moreover, we
also found a significant positive correlation between LPS
staining within the MesLN and within the matched AxLN
(r=0.59, P=0.027, Figure 6C). Taken together, these data
indicate that the presence of microbial products in the
peripheral lymphatic tissues is intimately linked to microbial
translocation from the gut.
Induction of immune activation: translocated microbial
products co-localize with markers of immune activation
Microbial products can directly stimulate the innate immune
system via interactions with Toll-like receptors (TLR) that lead to
an inflammatory cascade. To evaluate the possible relationship
between translocation of microbial products and inflammation we
performed double-label immunohistochemical staining for micro-
Figure 2. Identification of microbial translocation in large bowel of chronically SIV
+ RMs. Representative images (2006) of colon stained
with a polyclonal antibody against E. coli (brown) in SIV early acute infected (4 dpi) and chronically SIV-infected RMs (Non-AIDS and AIDS). Note the
small regions of epithelial discontinuities in the SIV
+ Non-AIDS RMs resulting in luminal E. coli
+ content in direct contact with the LP and increased
frequency of E. coli
+ cells within the LP. Sections from two SIV
+ AIDS RMs show the range of epithelial damage with associated microbial product
infiltration, findings frequently seen in RMs with AIDS. Arrows point to regions of epithelial discontinuities and microbial translocation into the LP.
doi:10.1371/journal.ppat.1001052.g002
Figure 3. Identification of microbial translocation in gut draining MesLN of chronically SIV
+ RMs. Representative images (2006) of the
paracortical T-cell zone of MesLN stained for LPS-core antigen (brown). Note the more extensive accumulation of microbial products within the T cell
zone, the T-cell inductive parenchyma of the lymphatic tissue with progressively more severe SIV infection.
doi:10.1371/journal.ppat.1001052.g003
Mechanisms Underlying Microbial Translocation
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Reflecting the immune activation of chronic SIV infection in RMs,
IFNa expression was widespread and we consistently demonstrat-
ed co-localization of IFNa and microbial products within the LP of
the colon (Figure S6), and in AxLN, and MesLN (data not shown).
The majority of such co-localization occurred in the absence of
detectable local viral replication, as during the chronic phase of
infection productively infected cells within the LP are only rarely
demonstrable by in situ hybridization in most SIV-infected RMs
that have not progressed to AIDS (data not shown). Indeed, in
extensive double label studies using immunohistochemical staining
for IFNa and in situ hybridization for SIV RNA in tissues from
chronically SIV-infected Non-AIDS RMs, there was only very
limited co-localization between IFNa expression and in situ
hybridization for SIV RNA in the colon or MesLN (data not
shown). The overwhelming majority of the abundant IFNa
immunostaining was found relatively distant from local viral
replication, but in close proximity to microbial products (data not
shown). Moreover, the levels of IFNa immunostaining were
significantly greater than the tissue level of SIV RNA.
To evaluate further the role of translocated microbial products
in driving immune activation in chronic SIV infection, we assessed
the distribution and co-localization of interleukin-18 (IL-18) and
LPS in the gut-draining MesLN in SIV-uninfected and chronically
SIV-infected Non-AIDS RMs (Figure S7). IL-18 is produced by
activated macrophages and dendritic cells in response to microbial
product stimulation [28]. We found that before SIV infection
there was a basal, low-level, expression of IL-18 in all structural
compartments of MesLN (i.e. B cell follicles, T-cell zone and
medullary cords) and that this expression was dramatically
increased in SIV infection (data not shown). Although IL-18 was
up-regulated in some regions where there were no visualized
microbial products, high levels of IL-18
+ cells were always found in
close proximity to LPS in MesLN (Figure S7). Consistent with a
role for translocated microbial products inducing immune
activation and IL-18 expression, Ahmad and colleagues recently
described significantly elevated levels of IL-18 in the serum of
HIV-infected/AIDS patients compared to those of HIV-seroneg-
ative healthy individuals [29]. Collectively, these data strongly
suggest that microbial products, which infiltrate the LP of the GI
tract, and then spread systemically, can directly stimulate the
immune system and contribute to chronic immune activation.
Timing and mechanisms of increased microbial
translocation
To determine how early during infection microbial transloca-
tion occurs, we compared microbial translocation into the LP of
the colon of RMs throughout the acute stage of SIV infection (1 to
28 dpi) in vaginally-challenged animals. With the exception of one
animal at 8 dpi, we found only very low levels of LPS
+ cells within
Figure 4. Identification of systemic microbial translocation in distant AxLN of chronically SIV
+ RMs. Representative images (2006) of the
paracortex of AxLN stained for LPS-core antigen (brown). Note the increased accumulation of microbial products within the paracortex, germinal
centers, and medullary chords of the lymphatic tissue, with progressive SIV infection in chronically SIV
+ RMs, but the paucity of LPS staining seen in
SIV-uninfected RMs.
doi:10.1371/journal.ppat.1001052.g004
Figure 5. Identification of microbial translocation in the liver of chronically SIV
+ RMs. Representative images (2006) of liver stained for
E. coli constituents (brown). Note the increasing accumulation of microbial products near and surrounding the portal tract in chronically SIV
+ RMs
with more severe disease but lack of microbial constituent staining seen in SIV-uninfected RMs.
doi:10.1371/journal.ppat.1001052.g005
Mechanisms Underlying Microbial Translocation
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indistinguishable from SIV-uninfected animals (Figures 6 and
data not shown). There was a statistically significant increase in
LPS seen within the LP of animals infected for between 14 and 28
days compared to uninfected or early/acute animals and evidence
of microbial translocation was detected at small foci associated
with breaks in the epithelial lining (Figures 6 and data not shown).
Importantly, during the acute phase of infection, areas of
discontinuity in the epithelial barrier were relatively infrequent,
while LPS staining in the LP appeared to increase into the late
acute stage of SIV infection (14–28 dpi). Interestingly the extent of
lesions and discontinuities were lower than might have been
expected relative to the massive enterocyte apoptosis previously
described as peaking at 14 dpi in these same animals [23]. We
comment below on the possible mechanisms responsible for this
dissociation.
Although enterocyte apoptosis subsequently decreased, even as
microbial translocation increased in the late acute stage of
infection, the abundant evidence of LPS
+ within the lamina
propria at 28 dpi suggested that early damage to the integrity of
the epithelial lining could facilitate translocation of microbial
products (data not shown). Thus, we sought to determine directly if
the compromise of the integrity of the epithelial barrier is a
distinguishing feature of microbial translocation during chronic
SIV infection, evaluating the integrity of the epithelial barrier by
staining for the tight junction protein claudin-3. A similar
technique has been used in studying human samples to assess
the integrity of the epithelial barrier in diseases associated with
discontinuities in the GI tract [30]. Examination of the integrity of
the epithelial barrier by staining for claudin-3, revealed multifocal
disruptions and epithelial loss of the normally continuous,
epithelial barrier in tissues from the chronic stages of infection,
but not in tissues from uninfected or early acute animals (Figure 7A
and Figure S8). We recognize the possible contribution that
undetected opportunistic enteric pathogens may play in the
continuum of epithelial damage seen in our chronically SIV-
infected (AIDS) RMs, and thus show in Figures 7 and S8 two
examples of end-stage RMs demonstrating this dynamic spectrum
of epithelial damage from multifocal epithelial loss to severe
epithelial damage and ulceration. Importantly, confocal analysis
showed that disruptions in the integrity of the epithelial barrier
were directly associated with translocated microbial products
(Figure 7B). Furthermore, quantitative image analysis from high
power entire colonic tissue section scans, confirmed that
chronically-infected animals had significantly more damage to
the integrity of the epithelial barrier compared to uninfected and
acutely-infected RMs (Figure 8A). Moreover, the degree to which
the integrity of the epithelial barrier was compromised was
significantly correlated with the amount of LPS within the LP
(Figure 8B; r=0.57, P=0.032).
Loss of integrity of the epithelial barrier of the GI tract would be
expected to result in several host responses including polymor-
phonuclear neutrophil (PMN) infiltration and increased local
proliferation of enterocytes within colonic crypts in an attempt to
restore the integrity of the GI tract. Importantly, we observed
increased levels of myeloperoxidase+ PMNs within the lamina
propria of chronically SIV-infected RMs associated with damage
to the epithelial barrier (Figure S9), providing strong evidence for a
tissue specific response to GI epithelial damage. To assess
proliferation of GI tract enterocytes we immunohistochemically
stained colon tissues with a monoclonal antibody against Ki67, a
cellular marker for proliferation, and performed quantitative
image analysis measuring the fraction of enterocytes along the
colonic crypt that were proliferating (Ki67
+). We found increased
levels of proliferating enterocytes (Ki67
+) in chronically SIV-
infected animals compared to SIV uninfected and acutely infected
RMs (Figure 9A–B and Figure S10, P=0.016). Moreover, there
was a trend towards an increase of Ki67
+ enterocytes in animals
between 14 and 28 days post SIV infection compared to animals
infected for ,1 week (Figure 9B, P=0.057). These data are
consistent with early (14–28 dpi) and progressive damage to the
integrity of the epithelial barrier, and indicate that one mechanism
underlying microbial translocation likely involves breakdown of
the structural barrier of the GI tract at a rate that exceeds
enterocyte proliferation and other repair mechanisms, consistent
with previous reports of abnormalities within the GI tracts of
chronically HIV or SIV-infected individuals [31,32,33,34,35,
36,37,38]. Our findings of host responses to microbial-product
infiltration into the lamina propria are consistent with previous
findings of fibrosis within the lamina propria of the GI tract [39].
While our data and those of previous studies are consistent with
increased discontinuity of the structural barrier of the GI tract
during chronic SIV infection of RMs, we cannot exclude that the
structural damage we observed by immunohistochemical analysis
may be attributed to increased enterocyte turnover overall, leading
to an apparent increase in structural damage to the GI tract.
Figure 6. Quantitative image analysis of microbial translocation. (A) Levels of LPS within the LP of the colon of SIV-uninfected (white squares),
early acute (white circles), late acute (gray circles), chronic Non-AIDS (black circles) and chronic AIDS (red circles) RMs. Mann-Whitney U test performed
between the chronically infected (both Non-AIDS and AIDS) and early acute RMs and between late acute and early acute RMs. (B) Correlation between
LPS levels within the LP of the colon and the mesenteric LN for animals in which we had obtained both colon and MesLN samples. Significance
determined using Spearman’s rank correlation coefficient and associated p-value shown. (C) Correlation between LPS levels within MesLN and AxLN for
animals in whichwehadobtainedboth MesLNandAxLN samples.Significancedeterminedusing Spearman’srank correlationcoefficientandassociated
P-value shown.
doi:10.1371/journal.ppat.1001052.g006
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the lamina propria of chronically SIV-infected RMs associated
with observed damage to the epithelial barrier (Figure S9), strongly
support our conclusion of GI epithelial damage. Regardless, these
data suggest that the integrity of the structural barrier of the GI
tract is significantly weakened in SIV-infected individuals leading
to microbial translocation.
Microbial translocation and phagocytosis by intestinal
macrophages
When microbial products cross the epithelial barrier under
normal, physiological conditions, they are generally phagocytosed
by specialized intestinal macrophages [40]. The relatively
abundant and apparently non-cell associated microbial constitu-
ents we saw in the LP of our chronically SIV-infected RMs,
particularly in animals with AIDS, suggested that this might result
from microbial translocation in excess of the phagocytic capacity
of these macrophages. This could reflect a saturation of the
maximum capacity of these macrophages to phagocytose translo-
cated microbial constituents or alternatively, might reflect a
compromise of macrophage phagocytic function resulting in a net
relative defect in microbial clearance and the extracellular
accumulation of microbial products. To assess this, we performed
confocal microscopy of GI tract tissue from SIV-uninfected and
acute and chronically SIV-infected RMs to assess the localization
of microbial constituents relative to GI tract macrophages
(intracellular vs. extracellular). In the rare instances where
microbial products were detected in the LP of SIV-uninfected
RMs, they were virtually always within HAM56
+ macrophages
(Figure 10 and Figure S11). In addition, during the acute phase of
infection (until 28 dpi), most microbial products were mostly found
within HAM56
+ macrophages (Figure S11), perhaps helping to
explain why LPS levels in plasma are not elevated during acute
infection while sCD14 levels were moderately raised [9].
Moreover, microbial products crossing the epithelial barrier at
14 dpi were virtually always found within macrophages, whereas
abundant macrophages were juxtaposed to damaged regions of
the colon in late acute (28 dpi) (Figure S11). Furthermore, as
infection progressed into the chronic stage of disease, the
frequency of macrophages negative for microbial products
increased, even though abundant numbers of macrophages were
present and adjacent to microbial products (Figure 10 and Figure
S11). There was no apparent change in the overall frequency of
HAM56
+ macrophages at the tips of the colonic crypts between
SIV-uninfected, and acutely or chronically SIV-infected RMs
(data not shown). The presence of high frequencies of macro-
Figure 7. Damage to the integrity of the epithelial barrier is associated with infiltration of microbial products into the lamina propria.
(A) Representative images (2006) of colon stained for the tight junction protein claudin-3 (brown) as a marker for intact epithelial barrier. Note the
multifocal regions of the epithelial barrier that are missing in SIV
+ RMs, allowing direct contact of luminal contents with the LP. (B) Confocal
immunofluorescent 3-D images of colon (4006) stained for cytokeratin (epithelial cells; green), E. coli (red) and DAPI (nuclei; blue). Discontinuities in the
epithelial barrier allowing translocation of microbial products into the LP are present in late acute SIV
+ RMs (14 dpi) and progressively more severe in
chronic Non-AIDS and chronic AIDS RMs (white arrows point to epithelial discontinuities and translocated microbial products). Scale bars =40 mm.
doi:10.1371/journal.ppat.1001052.g007
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abundant extracellular microbial products suggested that GI tract
macrophages in the later phase of acute infection and chronic
stages of disease may become increasingly incapable of phagocy-
tosing microbial products that translocate into the LP.
Maintenance of the epithelial barrier and lack of
microbial translocation in Sooty mangabeys
A distinguishing feature of non-progressive infection in natural
hosts of SIV is the absence of immune activation during the
chronic phase of infection [6,41,42,43,44,45]. Because elevated
plasma LPS levels are absent in both chronically SIVsmm-infected
SMs and SIVagm-infected AGMs [9,45,46], we evaluated the
structural integrity of the intestinal epithelial barrier in chronically
SIVsmm-infected SMs. In contrast to findings in chronically SIV-
infected RMs, and consistent with the lack of LPS within the
circulation of these SIV natural host animals [9], we found no
evidence of damage to the integrity of the epithelial barrier
(Figure 11A) and no infiltration of microbial products into the LP
of large bowel (Figure 11B) or peripheral lymph nodes
(Figure 11C). These data were consistent among 7 animals studied
(n=2, SIVsmm-uninfected SMs; n=5, chronically SIVsmm-
infected SMs; Table 1). Hence preservation of the tight epithelial
barrier is associated with lack of microbial translocation and
immune activation in non-progressive, natural SIV infection.
Discussion
Indirect evidence has implicated microbial translocation from
the gut as a factor contributing to pathological immune activation
in chronic HIV/SIV infection, but direct evidence of transloca-
tion and demonstration of a plausible underlying mechanism
have been lacking. Using an unbiased, comprehensive approach
for quantitative and qualitative immunohistologic analysis of
randomly selected tissue specimens obtained from non-human
primates at various times relative to SIV infection, we have
shown that: 1) microbial products can be found in the LP of the
large bowel, in draining and distant lymph nodes, and in the liver
of chronically SIV-infected RMs; 2) microbial translocation is
associated with breakdown of the integrity of the epithelial barrier
of SIV-infected RMs; 3) the extent of epithelial breakdown
correlates with the extent of microbial translocation; 4) epithelial
barrier breakdown and microbial translocation begin to be
Figure 8. Damage to the integrity of the epithelial barrier correlates with microbial translocation. (A) Quantitative image analysis
showing the proportion of the epithelial lining in the large bowel that is damaged (discontinuous) in SIV-uninfected (white squares), early acute
(white circles), late acute (gray circles), chronic Non-AIDS (black circles) and chronic AIDS (red circles) RMs. Mann-Whitney U test performed between
the chronically infected (both Non-AIDS and AIDS) and early acute RMs and between chronically infected (both Non-AIDS and AIDS) and SIV- RMs. (B)
Statistically significant positive correlation between the proportion of epithelial damage and the level of LPS within the LP of the colon. Significance
determined using Spearman’s rank correlation coefficient and associated P-value shown.
doi:10.1371/journal.ppat.1001052.g008
Figure 9. Damage to the integrity of the epithelial barrier is associated with increased enterocyte proliferation. (A) Representative
images (2006) of colon stained for the proliferative nuclear protein Ki67 (brown). Note progressive change in frequency and location of Ki67
+
enterocytes, from few cells at the base of crypts during early acute infection (4 dpi), with full involvement of crypts with proliferating cells in
chronically infected Non-AIDS and AIDS animals. (B) Quantitative image analysis of Ki67 expression by colonic enterocytes in early acute (white
circles), late acute (gray circles), chronic Non-AIDS (black circles) and chronic AIDS (red circles) RMs demonstrates the statistically significant increase
in enterocyte proliferation in chronic infection. Mann-Whitney U test performed between the chronically infected (both Non-AIDS and AIDS) and late
acute RMs and between early acute and late acute RMs.
doi:10.1371/journal.ppat.1001052.g009
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presence of microbial products in multiple anatomical sites is
associated with expression of IFN-a and IL-18 in the absence of
detectable local viral replication in the LP, consistent with direct
induction of immune activation; 6) macrophages in chronically
SIV-infected RMs appear dysfunctional with respect to their
ability to phagocytose translocated microbial products; and 7)
neither epithelial barrier breakdown nor infiltration of microbial
products into the LP occur during the chronic phase of SIV
infection of SMs.
Weprovidetwolinesofevidencelinkingmicrobialtranslocationto
immune activation. First, we show that in pathogenic SIV infection
of RMs, damage to the integrity of the epithelial barrier of the GI
tract is associated with microbial translocation, and that microbial
translocation is linked to local immune activation, based on co-
localization of microbial products and production of the immunoin-
flammatory cytokines IFNa and IL-18, including in lymph nodes
anatomically distant from the GI tract. Second, in marked contrast,
in SIV-infected SMs where immune activation is quickly resolved in
the acute stage of infection [47], and chronic infection is not
accompanied by persistent immune activation, we found neither
damage to the intestinal barrier nor microbial translocation.
Recent in vitro studies with peripheral blood lymphocytes from
SMs have been interpreted to suggest that a lack of type I IFN
cytokine response to SIV RNA accounts for the typically
nonprogressive nature of SIV infection in SMs [48]. Furthermore,
these data have been used to suggest that the raised plasma LPS
levels observed in chronically SIV-infected RMs and HIV-infected
humans, are simply markers of damage to the GI tract and that the
microbial translocation that is reflected in elevated plasma LPS
levels does not contribute significantly to causing systemic immune
activation [48]. However not only were LPS levels increased in
chronically-infected individuals, but sCD14 and LPS binding
protein levels were also increased [9,11,13]. These data strongly
suggested that LPS was directly stimulating the immune system in
vivo. In the present study, we show directly that damage to the
integrity of the epithelial barrier of the GI tract allows microbial
products to infiltrate into the LP and this infiltration is associated
with local immune activation demonstrated by co-localization of
microbial products within the LP with IFNa and IL-18 in MesLN.
As only limited viral replication is demonstrable in the LP of the
GI tract of chronically SIV-infected RMs, the damage to the GI
epithelial lining, microbial translocation and local immune
activation are unlikely to be caused by the direct effects of local
viral replication. Rather, where rare infected cells are seen in the
LP underlying damaged mucosa, it is more likely that the chronic
immune activation, due to translocated microbial products, has
provided activated CD4
+ T cell targets for the virus.
Taken together, these data suggest that microbial translocation,
resulting from damage to the GI tract epithelial barrier and
impaired macrophage-mediated phagocytosis, results in immune
activation during the chronic phase of HIV/SIV infection of
humans and RMs. Importantly, we found a significant correlation
between the extent of damage to the epithelial barrier of the colon
and the amount of LPS within the underlying mucosa and the
extent of translocated microbial products in draining and remote
lymph node tissues. The extent of microbial constituents present in
lymph node tissues correlated with the extent of local evidence of
immune activation, further substantiating the link. Moreover,
while we find that microbial translocation begins during the acute
phase of infection, our previous work had indicated that elevated
levels of microbial products were not seen in plasma until the
chronic phase [9]. Our data suggest that microbial products are
localized within tissue macrophages during the acute phase thus
limiting their circulation.
The causes of damage to the integrity of the epithelial barrier of
the GI tract are likely to be multifaceted, but in the chronic stages
of SIV infection seem unlikely to be due to direct virotoxic effects,
given the lack of association with very low levels of demonstrable
local viral replication in the LP relative to the extensive epithelial
damage. One possible mechanism may be related to the
preferential loss of Th17 cells in the GI tract in progressive
immunodeficiency lentiviral infections [25,26], because Th17 cells
produce cytokines important for enterocyte proliferation and
antibacterial defensins [49,50,51] and IL-17 has recently been
shown to suppress Th1-mediated damage to gut epithelium.
Importantly, preservation of this T cell subset in the gut of
chronically SIVsmm-infected SMs and SIVagm-infected AGMs
[26,52] and the sparing of the epithelial barrier of SIVsmm
infected SMs we show here supports this mechanism.
Figure 10. Microbial products are differentially phagocytosed in acutely and chronically SIV-infected RMs. Confocal
immunofluorescent 3-D images of colon (4006) stained for HAM56 (macrophages; green), E. coli (red) and DAPI (nuclei; blue) showing the
progressive decrease in the fraction of microbial products (E. coli, red) internalized by macrophages (green, highlighted by white arrows), and an
increase in the proportion that were not cell associated with progressively more severe SIV infection. For specimens obtained from animals with later
stages of infection, the presence of abundant HAM56+ macrophages (green) without internalized E. coli constituents (red) (highlighted by white
arrow heads), despite extensive E. coli constituents present in the LP near macrophages, suggests that macrophages in chronic SIV
+ RMs become less
able to efficiently clear microbial products translocated into the LP. Rare microbial constituents are present in SIV-uninfected RMs but are virtually
always found within macrophages. Scale bars =40 mm.
doi:10.1371/journal.ppat.1001052.g010
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Representative images (2006) of rectum stained for the tight junction protein claudin-3 (brown) show the complete maintenance of the epithelial
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activation, microbial translocation and chronic stages of SIV
infection, and similarly, later stages of HIV-1 infection, reflects
damage to the structural integrity of the GI tract and a potential
‘‘deficiency’’ of the GI tract macrophage-phagocytic system. Our
observation that intestinal macrophages from SIV-infected RMs,
which are generally not proinflammatory [40], are unable to clear
translocated microbial products, within the LP, and could lead to
increased proinflammatory responses locally are supported by
several groups findings that showed: i) impaired monocyte
phagocytosis in HIV-infected individuals [53]; ii) reduced LPS-
mediated enhancement of phagocytosis in monocytes HIV-infected
individuals compared to healthy donors [54]; and iii) significantly
higher colonic mucosa proinflammatory mRNA expression levels
(e.g. TNF-a,I F N - c, and IL-6) in HIV-infected patients than in
control patients [55]. These data certainly warrant further
investigation into the functional properties of tissue macrophages
from HIV/SIV-infected individuals and the mechanisms underly-
ing their apparent dysfunction. While increased microbial translo-
cation begins in the late acute stage of SIV infection, it was not until
the later stages of infection that the capacity of macrophages for
clearance was apparently affected, suggesting that microbial
translocation has an increasing major contribution to immune
activation as the host progresses towards disease. The evidence for
this model comes from images of MesLN and AxLN stained for
bacterial products in the chronic stage that showed dramatically
increased extracellular bacterial constituents in the late AIDS stage
of SIV infection, versus the mainly cellular staining of LPS at earlier
stages. Taken together, these data strongly suggest that in SIV
infection of RMs, and by extension, HIV infection of humans,
damage to the epithelial barrier of the GI tract leads to levels of
microbial translocation that exceed the capacity of host defense
mechanisms to sequester away microbial constituents from
secondary lymphatic tissues, resulting in persistent immune
activation that contributes importantly to pathogenesis during the
chronic phase of infection. Understanding the factors underlying
damage to the integrity of the epithelial barrier and macrophage
deficiencies that we report may lead to novel therapeutic
interventions that aim to reduce microbial translocation and the
deleterious effects of the consequent immune activation.
Materials and Methods
Animals and tissues
To characterize the extent of microbial translocation in the
gastrointestinal tract in SIV infection, we studied tissues from an
assembled cohort of SIV-uninfected and infected RMs and
SIVsmm-infected and uninfected SMs originally involved in
separate studies (summarized in Table 1). Tissues (colon and
LNs) were obtained at necropsy from 13 rhesus macaques (Macaca
mulatta) of Indian origin euthanized 1–28 days after atraumatic
intravaginal infection with SIVmac251 or SIVmac239 as
described elsewhere [56]. Six additional SIV-negative RMs were
used as controls. In a separate study, tissues were obtained at
necropsy from 13 adult RMs chronically infected with SIVmac239
or SIVsmE660 that were sacrificed either because of end-stage
disease (AIDS; defined by opportunistic infections, lymphomas, or
a diagnosis of wasting, based on greater than 15% body mass
weight loss, n=5) or protocol specified experimental end point
(Non-AIDS; n=8). For immunohistochemistry studies, samples
were very quickly processed into fixative to avoid potential artifacts
associated with post-mortem tissue changes. The post mortem
interval, the time from euthanasia until collection of lymph nodes
and GI tract segments were placed into fixative, ranged from
,10–30 minutes and was consistent over four independent
primate facilities contributing tissues to the present study. The
GI tract segments sampled at necropsy were representative and
were not selected with regard to any visually apparent lesions or
other pathology. In a third study, LNs and rectal biopsies were
obtained from 2 SIVsmm-negative SMs (Cercocebus atys) and 5 SMs
that were naturally infected with SIVsmm as previously described
[47]. Animals were housed and cared in accordance with
American Association for Accreditation of Laboratory Animal
Care standards in AAALAC accredited facilties, and all animal
procedures were performed according to protocols approved by
the Institutional Animal Care and Use Committees of the National
Cancer Institute, California National Primate Research Center or
Yerkes National Primate Research Center (Table 1). Unfortu-
nately, paraffin-embedded tissue from colon, mesLN, and axLN
samples were not available from all animals.
Plasma viral loads
Plasma samples were analyzed for SIV vRNA by using a
quantitative branched DNA (bDNA) assay [53] or using a
fluorescent resonance energy transfer probe-based real-time RT-
PCR (TaqMan) assay that provides a threshold sensitivity of 125
copy Eq/ml, as previously described [57]. All PCR reactions were
run on ABI Prism 7700 Sequence Detection System and the
fluorescent signal-based quantitation of viral RNA copy numbers
in test samples was determined by ABI sequence detection
software (Applied Biosystems, Foster City, CA).
Immunohistochemistry, ISH and FISH
Immunohistochemical staining and SIV in situ hybridization
were performed as previously described [58]. In brief, unselected
specimens of tissues of interest were obtained at necropsy, fixed,
and paraffin embedded. Immunohistochemistry was performed
using a biotin-free polymer approach (MACH-3; Biocare Medical)
on 5-mm tissue sections mounted on glass slides, which were
dewaxed and rehydrated with double-distilled water. Antigen
retrieval was performed by heating sections in 16 DIVA
Decloaker reagent (Biocare Medical) in a pressure cooker (Biocare
Medical) followed by cooling to room temperature. All slides were
stained using the intelliPATH FLX autostaining system (Biocare
Medical) according to experimentally determined optimal condi-
tions. This included blocking tissues with Blocking Reagent
(Biocare Medical) for 10 min followed by an additional blocking
step with TNB (0.1 M Tris-HCL (pH 7.5), 0.15 M NaCl, and
0.5% Blocking Reagent (NEN)) containing 2% Blocking Reagent
and 100 mg/mL goat ChromePure IgG (Jackson Immunore-
search) for 10 minutes at room temperature. Endogenous
peroxidase was blocked with 1.5% (v/v) H2O2 in TBS (pH 7.4).
Primary antibodies were diluted in TNB containing 2% Blocking
Reagent and 100 mg/mL goat ChromePure IgG for 1 h at room
temperature. Mouse or rabbit MACH-3 secondary polymer
systems (Biocare Medical) were applied for 20 minutes each.
Double immunohistochemical staining was performed on colon
and lymph node sections with either mouse monoclonal anti-LPS-
core and rabbit polyclonal anti-IL18 antibodies or mouse
barrier in SIVsmm-uninfected and SIVsmm-infected SMs. Representative images (2006)o f( B) rectum and (C) peripheral lymph nodes (1006) stained
for LPS-core antigen (brown) shows the absence of microbial translocation in SIVsmm-uninfected and SIVsmm-infected SMs.
doi:10.1371/journal.ppat.1001052.g011
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MACH-2 multiplex staining system (Biocare Medical) according
to manufacturer’s instructions. Sections were developed with
ImmPACT DAB (Vector Laboratories) and/or Vulcan Fast Red
chromogen (Biocare Medical), counterstained with hematoxylin,
and mounted in Permount (Fisher Scientific).
All stained slides were scanned at high magnification (4006)
using the ScanScope CS System (Aperio Technologies, Inc.)
yielding high-resolution data from the entire tissue section.
Bacterial PNA FISH was performed using the universal bacterial
16 s ribosomal RNA specific (UniBac) FITC conjugated PNA
probe (AdvanDx, Inc.) according to manufacturer’s instructions,
with the exception that a heat induced epitope retrieval
pretreatment step was performed in 16 Diva retrieval buffer
(Biocare Medical) for 20 minutes in a 95uC water bath prior to
hybridization. FISH samples were examined and imaged using a
Nikon 80i upright fluorescent microscope (Nikon Instruments, Inc)
equipped with a BrightLine multiband bandpass FITC/Texas
Red filter (Semrock; data not shown). Primary antibodies used
were: mouse anti-human Interferon-a (clone MMHA-2; PBL
InterferonSource), mouse anti-LPS core (clone WN1 222-5;
Hycult or provided by Dr. Robin Barclay), mouse anti-
macrophage (clone HAM56; Dako), mouse anti-cytokeratin (clone
MNF116; Dako), polyclonal rabbit anti-E. coli (Dako), polyclonal
rabbit anti-IL-18 (Sigma Prestige Antibodies by Atlas Antibodies)
and polyclonal rabbit anti-Claudin-3 (Labvision).
Confocal fluorescent microscopy
Immunofluorescent confocal microscopy was performed on
treated slides as above, but stained overnight with primary
antibodies at 4uC, washed, stained with fluorescently conjugated
secondary antibodies for 1 h in the dark, counterstained with
DAPI (Molecular Probes), mounted in AquaPoly mount (Poly-
sciences, Inc.) and imaged using a Olympus FluoView FV1000. Z-
stack images were taken for each high power field that spanned the
entire 5 mm tissue section and representative 3-D projections from
z-stack images were generated using Imaris 7.0.0 software
(Bitplane Inc.). Secondary antibodies used were donkey anti-
mouse IgG Alexa Fluor 488 and donkey anti-rabbit IgG Alexa
Fluor 555 (all from Molecular Probes).
Quantitative image analysis
To quantify microbial translocation (LPS) into the LP and the
extent of epithelial barrier damage (claudin-3), 5-mm thick sections
were cut from paraffin blocks of unselected tissue sections obtained
at necropsy and stained with either monoclonal antibody against
LPS-core or polyclonal antibody for claudin-3 and counter stained
with heamotoxalin. High power (4006) whole tissue scans were
obtained using an Aperio ScanScope as described above and
imported into Photoshop CS3 (Adobe Systems Inc., Mountain
View, California, USA). Images were manually trimmed to
remove the submucosae, muscularis and residual luminal content,
leaving only the LP mucosae to analyze. The percent area of the
LP staining for LPS was determined essentially as previously
described using Photoshop CS3 tools with plug-ins from Reindeer
Graphics [39,47]. The percent area of LN staining for LPS was
determined from whole LN scans as above but without the need to
trim the image. The proportion of the epithelial barrier that was
damaged during SIV infection was first determined by manually
tracing (in red) the area of the lumen/GI epithelial tract interface
that had no claudin-3 staining epithelial cells, using the brush tool
in Photoshop CS3. The remaining claudin-3 staining intact
epithelial cell regions were then manually traced (in black). The
percent damage was calculated by determining the proportion of
the image that was red (lack of claudin-3 stain) compared to the
total epithelial surface area (red+black) using plug-in tools from
Reindeer Graphics.
Statistical tests
Spearman’s rank correlation and Mann-Whitney tests were
performed using Prism 4.0 software (Prism, San Diego, CA).
Supporting Information
Figure S1 Identification of microbial translocation (LPS) in large
bowel of chronically SIV
+ RMs. Low magnification whole tissue
(top panel), 406(middle panel) and 1006(bottom panel) images
from high power whole tissue scans of colon immunohistochem-
ically stained for LPS-core antigen (brown). Rectangles represent
regions of the colon magnified in the successive images, while the
rectangles displayed in the 1006lower panel images represent the
region magnified and displayed in Figure 1. Scale bars =1 mm.
Found at: doi:10.1371/journal.ppat.1001052.s001 (4.38 MB TIF)
Figure S2 Identification of microbial translocation (E. coli)i n
large bowel of chronically SIV
+ RMs. Low magnification whole
tissue (top panel), 406 (middle panel) and 1006 (bottom panel)
images from high power whole tissue scans of colon immunohis-
tochemically stained with a polyclonal antibody against E. coli
(brown). Rectangles represent regions of the colon magnified in the
successive images, while the rectangles displayed in the 1006
lower panel images represent the region magnified and displayed
in Figure 2. Scale bars =1 mm.
Found at: doi:10.1371/journal.ppat.1001052.s002 (4.42 MB TIF)
Figure S3 Identification of microbial translocation in gut
draining MesLN of chronically SIV
+ RMs. Low magnification
whole tissue (top panel), 406 (middle panel) and 1006 (bottom
panel) images from high power whole tissue scans of MesLN
immunohistochemically stained for LPS-core antigen (brown).
Rectangles represent regions of the colon magnified in the
successive images, while the rectangles displayed in the 1006
lower panel images represent the region magnified and displayed
in Figure 3. Scale bars =1 mm.
Found at: doi:10.1371/journal.ppat.1001052.s003 (5.35 MB TIF)
Figure S4 Identification of microbial translocation in systemic
distal AxLN of chronically SIV
+ RMs. Low magnification whole
tissue (top panel), 406 (middle panel) and 1006 (bottom panel)
images from high power whole tissue scans of AxLN immunohis-
tochemically stained for LPS-core antigen (brown). Rectangles
represent regions of the colon magnified in the successive images,
while the rectangles displayed in the 1006 lower panel images
represent the region magnified and displayed in Figure 4. Scale
bars =1 mm.
Found at: doi:10.1371/journal.ppat.1001052.s004 (5.24 MB TIF)
Figure S5 Identification of microbial translocation (E. coli) in the
liver of chronically SIV
+ RMs. Low magnification whole tissue
(top panel), 406(middle panel) and 1006(bottom panel) images
from high power whole tissue scans of liver immunohistochem-
ically stained with a polyclonal antibody against E. coli (brown).
Rectangles represent regions of the colon magnified in the
successive images, while the rectangles displayed in the 1006
lower panel images represent the region magnified and displayed
in Figure 5. In 406 and 1006 images, arrows point to portal
triads, while arrow heads point to central veins. Scale bars =
1 mm.
Found at: doi:10.1371/journal.ppat.1001052.s005 (4.89 MB
TIF)
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IFNa
+ cells in colon. Images (2006) of colon stained for both E.
coli (brown) and IFNa (red) from uninfected and chronically SIV-
infected Non-AIDS and AIDS RMs.
Found at: doi:10.1371/journal.ppat.1001052.s006 (8.30 MB TIF)
Figure S7 Spatial localization of microbial products with an
effector marker of immune activation, IL-18, in MesLN. Images
(4006) of MesLN stained for both LPS (brown) and IL-18 (red)
from uninfected and SIV-infected Non-AIDS RMs. Note the
spatial proximity of LPS
+ cells and extracellular LPS with IL-18
+
cells in MesLN. Scale bars =50 mm.
Found at: doi:10.1371/journal.ppat.1001052.s007 (10.20 MB
TIF)
Figure S8 Damage to the integrity of the epithelial barrier in
chronic SIV
+ RMs. Low magnification whole tissue (top panel),
406 (middle panel) and 1006 (bottom panel) images from high
power whole tissue scans of colon from SIV uninfected and
chronically SIV
+ RMs immunohistochemically stained for the
tight junction protein claudin-3 (brown). Rectangles represent
regions of the colon magnified in the successive images, while the
rectangles displayed in the 1006lower panel images represent the
region magnified and displayed in Figure 7. Scale bars =1 mm.
Found at: doi:10.1371/journal.ppat.1001052.s008 (4.68 MB TIF)
Figure S9 GI tract damage results in PMN infiltration within
the colon of chronically SIV
+ RM. (A) Representative images
(2006) of the colon stained for myeloperoxidase (brown) as a
marker for PMNs. Note the increasing accumulation of myelo-
peroxidase+ PMNs adjacent to epithelial lesions in chronically
SIV
+ RM, reflecting a tissue response to loss of epithelial integrity,
but the lack of this association seen in early acute SIV
+ RM (4 dpi).
(B) Random high power 4006 images (10–15) of gut LP were
taken and the percent area staining for myeloperoxidase (PMN)
were determined in early/acute and chronic SIV
+ RM.
Found at: doi:10.1371/journal.ppat.1001052.s009 (3.11 MB TIF)
Figure S10 Damage to the integrity of the epithelial barrier is
associated with increased enterocyte proliferation. Low magnifi-
cation whole tissue (top panel), 406 (middle panel) and 1006
(bottom panel) images from high power whole tissue scans of colon
from SIV uninfected and chronically SIV
+ RMs immunohisto-
chemically stained for Ki67 (brown). Rectangles represent regions
of the colon magnified in the successive images, while the
rectangles displayed in the 1006 lower panel images represent
the region magnified and displayed in Figure 9. Scale bars =
1 mm.
Found at: doi:10.1371/journal.ppat.1001052.s010 (4.66 MB TIF)
Figure S11 Quantitative image analysis of the frequency of
HAM56
+ macrophages that are E. coli
+ compared to the
proportion of HAM56
2 E.coli
+ events in SIV-uninfected and
acutely and chronically SIV-infected RMs. Note that throughout
the acute phase of infection (1–21 dpi), most microbial products
are within or associated with macrophages, however, starting at 28
dpi and extending into the chronic stage macrophages, although
still abundant in the GI tract, become progressively inefficient/
dysfunction in their ability to bind and/or phagocytose microbial
products that cross the epithelial barrier.
Found at: doi:10.1371/journal.ppat.1001052.s011 (0.13 MB TIF)
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